Literature DB >> 2200612

Thrombospondin expression in traumatized skeletal muscle. Correlation of appearance with post-trauma regeneration.

S C Watkins1, G W Lynch, L P Kane, H S Slayter.   

Abstract

Biochemical and immuno-microscopic techniques were used to study temporal involvement of thrombospondin in relation to fibrinogen in muscle regeneration using a rat skeletal muscle-wound model. In undamaged control muscle, no fibrinogen and minimal thrombospondin antigen was found. Following crushing injury, fibrin networks appear immediately, followed by a gradual ordered accumulation of thrombospondin (within a few hours) in the vicinity of the vascular bed and adjacent endomysial connective tissue. Later, thrombospondin becomes associated with connective tissue and basal laminae around muscle fibers throughout the damaged muscle, maximal labelling occurring 3-6 days post-injury. Thrombospondin immunoreactivity decreased thereafter to near normal levels after 7 days post-injury, coincident with the appearance of regenerating muscle fibers. In contrast, little fibrin material remained by five days after injury. Quantitative radioimmunoassay of soluble thrombospondin antigen and radioimmune labelling of thick frozen sections reinforced the qualitative immuno-microscopic observations, with levels peaking at 3-4 days post-trauma, 10-fold over control levels. SDS-PAGE immunoblotting of non-reduced muscle extracts three days after a crush assault shows that the bulk of the thrombospondin incorporated into the injury site exists in a polymerized state (less than or equal to 1000 kD). These results demonstrate that the temporal appearance and disappearance of thrombospondin in the healing of a crushing lesion in muscle is related more closely to the regeneration phase of muscle than to the coagulation phase.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2200612     DOI: 10.1007/bf00329440

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  49 in total

1.  Isolation and characterization of a high molecular weight glycoprotein from human blood platelets.

Authors:  J W Lawler; H S Slayter; J E Coligan
Journal:  J Biol Chem       Date:  1978-12-10       Impact factor: 5.157

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Use of a radioimmunoassay to quantify thrombospondin.

Authors:  S D Saglio; H S Slayter
Journal:  Blood       Date:  1982-01       Impact factor: 22.113

Review 4.  Skeletal muscle regeneration.

Authors:  D Allbrook
Journal:  Muscle Nerve       Date:  1981 May-Jun       Impact factor: 3.217

5.  Platelet thrombospondin haemagglutinin activity is due to aggregate formation.

Authors:  W J Booth; P A Castaldi; M C Berndt
Journal:  Thromb Res       Date:  1985-07-01       Impact factor: 3.944

6.  The complex multimeric composition of factor VIII/von Willebrand factor.

Authors:  Z M Ruggeri; T S Zimmerman
Journal:  Blood       Date:  1981-06       Impact factor: 22.113

7.  Characterization of thrombospondin as a substrate for factor XIII transglutaminase.

Authors:  G W Lynch; H S Slayter; B E Miller; J McDonagh
Journal:  J Biol Chem       Date:  1987-02-05       Impact factor: 5.157

8.  Synthesis and secretion of thrombospondin by cultured human endothelial cells.

Authors:  D F Mosher; M J Doyle; E A Jaffe
Journal:  J Cell Biol       Date:  1982-05       Impact factor: 10.539

9.  Immunoelectron microscopic studies of desmin (skeletin) localization and intermediate filament organization in chicken cardiac muscle.

Authors:  K T Tokuyasu; A H Dutton; S J Singer
Journal:  J Cell Biol       Date:  1983-06       Impact factor: 10.539

10.  Interaction of human thrombospondin with types I-V collagen: direct binding and electron microscopy.

Authors:  N J Galvin; P M Vance; V M Dixit; B Fink; W A Frazier
Journal:  J Cell Biol       Date:  1987-05       Impact factor: 10.539

View more
  9 in total

Review 1.  Thrombospondin as a mediator of cancer cell adhesion in metastasis.

Authors:  D A Walz
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

2.  Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia.

Authors:  J Lawler; M Sunday; V Thibert; M Duquette; E L George; H Rayburn; R O Hynes
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

Review 3.  The thrombospondins.

Authors:  Josephine C Adams; Jack Lawler
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-10-01       Impact factor: 10.005

4.  Functional effects of LC1-reassociation with cardiac papain Mg.S1.

Authors:  S S Margossian; H D White; J Lefford; J C Holt; A Malhotra; W F Stafford; H S Slayter
Journal:  J Muscle Res Cell Motil       Date:  1993-02       Impact factor: 2.698

5.  Cell-type specific adhesive interactions of skeletal myoblasts with thrombospondin-1.

Authors:  J C Adams; J Lawler
Journal:  Mol Biol Cell       Date:  1994-04       Impact factor: 4.138

6.  Thrombospondin in human glomerulopathies. A marker of inflammation and early fibrosis.

Authors:  B McGregor; S Colon; M Mutin; E Chignier; P Zech; J McGregor
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

7.  Stimulation of fascin spikes by thrombospondin-1 is mediated by the GTPases Rac and Cdc42.

Authors:  J C Adams; M A Schwartz
Journal:  J Cell Biol       Date:  2000-08-21       Impact factor: 10.539

8.  Regulation of Female Folliculogenesis by Tsp1a in Nile Tilapia (Oreochromis niloticus).

Authors:  Mimi Jie; He Ma; Li Zhou; Jiahong Wu; Minghui Li; Xingyong Liu; Deshou Wang
Journal:  Int J Mol Sci       Date:  2020-08-16       Impact factor: 5.923

9.  Hepatic Steatosis Contributes to the Development of Muscle Atrophy via Inter-Organ Crosstalk.

Authors:  Kenneth Pasmans; Michiel E Adriaens; Peter Olinga; Ramon Langen; Sander S Rensen; Frank G Schaap; Steven W M Olde Damink; Florian Caiment; Luc J C van Loon; Ellen E Blaak; Ruth C R Meex
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-11       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.